3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
6
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
196
Neoplasms
104
Colorectal Neoplasms
91
Stomach Neoplasms
80
Uterine Cervical Neoplasms
71
Carcinoma, Non-Small-Cell Lung
67
Carcinoma, Hepatocellular
54
Prostatic Neoplasms
48
Lung Neoplasms
48
Rectal Neoplasms
46
Esophageal Neoplasms
39
Pancreatic Neoplasms
37
Colonic Neoplasms
36
Ovarian Neoplasms
35
Recurrence
33
Head and Neck Neoplasms
33
Neoplasm Metastasis
28
Motor Activity
28
Multiple Myeloma
27
Small Cell Lung Carcinoma
26
Melanoma
25
Polycystic Ovary Syndrome
24
Lymphoma, Non-Hodgkin
24
Lymphoma
24
Leukemia, Myeloid, Acute
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Pain
20
Brain Neoplasms
20
Nasopharyngeal Carcinoma
18
Hematologic Neoplasms
17
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Interventional
×
Hepatic Insufficiency
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled